Turning a blind eye to deferasirox's toxicity?

Lancet. 2013 Apr 6;381(9873):1183-4. doi: 10.1016/S0140-6736(13)60799-0.
No abstract available

Publication types

  • Letter

MeSH terms

  • Age Factors
  • Benzoates / adverse effects*
  • Cause of Death
  • Chronic Disease
  • Deferasirox
  • Drug Approval
  • Europe
  • Hematologic Diseases / drug therapy
  • Humans
  • Iron Chelating Agents / adverse effects*
  • Iron Overload / drug therapy
  • Triazoles / adverse effects*

Substances

  • Benzoates
  • Iron Chelating Agents
  • Triazoles
  • Deferasirox